Baseline Quality of Life of Physical Function Is Highly Relevant for Overall Survival in Advanced Rectal Cancer

Baseline Quality of Life of Physical Function Is Highly Relevant for Overall Survival in Advanced Rectal Cancer

In advanced rectal cancer, neoadjuvant radiochemotherapy and total mesorectal excision lead to long overall survival. The quality of life (QOL) of the patients is clearly related to the prognosis. Our question was whether the prognosis can be represented with only one question or one score from the...

Full description

Bibliographic Details
Main Authors:	Tim Fitz, Christopher Sörgel, Sandra Rutzner, Markus Hecht, Rainer Fietkau, Luitpold V. Distel
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Series:	Healthcare
Subjects:	rectal cancer physical function radiochemotherapy quality of life age
Online Access:	https://www.mdpi.com/2227-9032/10/1/141

Similar Items

Impact of COVID-19 on Quality of Life in Long-Term Advanced Rectal Cancer Survivors
by: Daniel Blasko, et al.
Published: (2023-07-01)

Substantial Impairment of Quality of Life during COVID-19 Pandemic in Patients with Advanced Rectal Cancer
by: Irene Dennison, et al.
Published: (2022-08-01)

Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer
by: Barbara Schuster, et al.
Published: (2021-12-01)

Preoperative Radiochemotherapy in Rectal Cancer: Is There an Impact of Oxaliplatin on Pathologic Complete Response and Survival Rates under “Real World“ Conditions?
by: Alexander Grabenbauer, et al.
Published: (2023-01-01)

Side Effects and Disease-Free Survival with Capecitabine Compared to 5FU for Concurrent Radiochemotherapy of Rectal Cancer: A 5-year Review
by: Peiman Haddad, et al.
Published: (2014-01-01)

Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using <sup>18</sup> F-FDG PET-CT imaging. A prospective clinical study
by: Goldberg Natalia, et al.
Published: (2012-08-01)

Total neoadjuvant treatment of locally advanced rectal cancer with high risk factors in Slovenia
by: Tuta Mojca, et al.
Published: (2019-10-01)

Prognostic significance of tumor regression in locally advanced rectal cancer after preoperative radiochemotherapy
by: Omejc Mirko, et al.
Published: (2017-12-01)

Expression Levels of GHRH-Receptor, pAkt and Hsp90 Predict 10-Year Overall Survival in Patients with Locally Advanced Rectal Cancer
by: Dávid Fodor, et al.
Published: (2023-02-01)

Pathological complete response due to a prolonged time interval between preoperative chemoradiation and surgery in locally advanced rectal cancer: analysis from the German StuDoQ|Rectalcarcinoma registry
by: Sven Lichthardt, et al.
Published: (2020-01-01)

Late Local Recurrence after Neoadjuvant Therapy and Radical Resection for Locally Advanced Rectal Cancer
by: Adrian Salega, et al.
Published: (2024-01-01)

Prognostic value of the micronucleus assay for clinical endpoints in neoadjuvant radiochemotherapy for rectal cancer
by: Leif Hendrik Dröge, et al.
Published: (2021-03-01)

Differences in and Prognostic Value of Quality of Life Data in Rectal Cancer Patients with and without Distant Metastases
by: Fabian Frank, et al.
Published: (2020-12-01)

Capecitabine-Induced Ileitis during Neoadjuvant Pelvic Radio-Chemotherapy for Locally Advanced Rectal Cancer: A Case Report with Literature Review
by: Andrea Brignoli, et al.
Published: (2023-10-01)

Clinical Reality and Treatment for Local Recurrence of Rectal Cancer: A Single-Center Retrospective Study
by: Michał Jankowski, et al.
Published: (2021-03-01)

Organ preservation in rectal cancer – Challenges and future strategies
by: C. Gani, et al.
Published: (2017-04-01)

High-Risk Clinicopathological and Genetic Features and Outcomes in Patients Receiving Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer
by: Sofía del Carmen, et al.
Published: (2021-06-01)

Predictive Factors of Histological Response after Preoperative Concomitant Radiochemotherapy in Middle and Low Rectal Cancer
by: Asmae Ouabdelmoumen, et al.
Published: (2018-09-01)

8-Oxoguanine DNA Glycosylase (OGG1) Cys326 Variant: Increased Risk for Worse Outcome of Patients with Locally Advanced Rectal Cancer after Multimodal Therapy
by: Martin Leu, et al.
Published: (2021-06-01)

LincRNA-p21 Levels Relates to Survival and Post-Operative Radiotherapy Benefit in Rectal Cancer Patients
by: Yan Li, et al.
Published: (2020-08-01)

The Conditioning of Adjuvant Chemotherapy for Stage II and III Rectal Cancer Determined by Postoperative Pathological Characteristics in Romania
by: Horia-Dan Liscu, et al.
Published: (2023-06-01)

Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancer
by: Armin Jarosch, et al.
Published: (2018-02-01)

Baseline liver steatosis has no impact on liver metastases and overall survival in rectal cancer patients
by: Giulia Besutti, et al.
Published: (2021-03-01)

Role of tumor cell senescence in non-professional phagocytosis and cell-in-cell structure formation
by: Dorian Gottwald, et al.
Published: (2020-11-01)

The Prognostic Value of FoxP3+ Tumour-Infiltrating Lymphocytes in Rectal Cancer Depends on Immune Phenotypes Defined by CD8+ Cytotoxic T Cell Density
by: Sören Schnellhardt, et al.
Published: (2022-01-01)

The Elevated Pre-Treatment C-Reactive Protein Predicts Poor Prognosis in Patients with Locally Advanced Rectal Cancer Treated with Neo-Adjuvant Radiochemotherapy
by: Richard Partl, et al.
Published: (2020-10-01)

Nomogram for individually predicting overall survival in rectal neuroendocrine tumours
by: Xingyu Feng, et al.
Published: (2020-09-01)

PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma
by: Holger H. Göbel, et al.
Published: (2022-05-01)

NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial)
by: Antoine Brouquet, et al.
Published: (2020-05-01)

Nomogram Predicting Overall Survival of Resected Locally Advanced Rectal Cancer Patients with Neoadjuvant Chemoradiotherapy
by: Song J, et al.
Published: (2020-08-01)

Preoperative intensity-modulated chemoradiation therapy with simultaneous integrated boost in rectal cancer: 2-year follow-up results of phase II study
by: But-Hadzic Jasna, et al.
Published: (2018-02-01)

Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc+ Monocytes in Rectal Cancer
by: Felix Wagner, et al.
Published: (2019-03-01)

Palbociclib Induces Senescence in Melanoma and Breast Cancer Cells and Leads to Additive Growth Arrest in Combination With Irradiation
by: Tina Jost, et al.
Published: (2021-10-01)

An investigation into tumor regression grade as a parameter for locally advanced rectal cancer and 5-year overall survival rate
by: Supparerk Laohawiriyakamol, et al.
Published: (2023-02-01)

Human papillomavirus infection predicts better survival rate in patients with an oropharyngeal cancer
by: Piotr Kędzierawski, et al.
Published: (2020-09-01)

Regulatory T cells and cytotoxic T cells close to the epithelial–stromal interface are associated with a favorable prognosis
by: Julian Rudolf, et al.
Published: (2020-01-01)

Long-Term Follow-Up of Patients Receiving Neoadjuvant Treatment Modalties for Soft Tissue Sarcomas of the Extremities
by: Miriam Rauch, et al.
Published: (2021-10-01)

Prognostic value of some tumor markers in unresectable stage IV oropharyngeal carcinoma patients treated with concomitant radiochemotherapy
by: Soba Erika, et al.
Published: (2015-12-01)

CD8+ and Regulatory T cells Differentiate Tumor Immune Phenotypes and Predict Survival in Locally Advanced Head and Neck Cancer
by: Alessia Echarti, et al.
Published: (2019-09-01)

Pathologic-Based Nomograms for Predicting Overall Survival and Disease-Free Survival Among Patients with Locally Advanced Rectal Cancer
by: Liu S, et al.
Published: (2021-02-01)